Generated by All in One SEO v5.0.0.1, this is an llms.txt file, used by LLMs to index the site.

# Provigate, Inc.

Provigateは低/非侵襲・低コスト・モチベーティブな 在宅型週次血糖モニタリングサービスの普及を通し 糖尿病の発症と重症化の予防を支援します。

## Sitemaps

- [XML Sitemap](https://provigate.com/sitemap.xml): Contains all public & indexable URLs for this website.

## 固定ページ

- [Home](https://provigate.com/) - プロヴィゲートは家庭向け血糖測定センサ・機器の開発及び、糖尿病が気になる方や糖尿病がある方向けの血糖モニタリングアプリの開発しています。在宅型週次血糖モニタリングサービスの普及を通し糖尿病の発症と重症化の予防を支援し、糖尿病のスティグマを解消します。
- [News](https://provigate.com/news-listing/)
- [News](https://provigate.com/en/news-listing/) - List of Provigate Inc. announcements. Please click here to see the latest information.
- [Career](https://provigate.com/career/) - 仕事人生を賭ける価値がここには有ります。ヘルスケアの大変革の時代に「世界人類に貢献する仕事」を成し遂げませんか。Provigateは才能と熱意にあふれた皆さまのご参画をお待ちしています。
- [お問い合わせ 完了](https://provigate.com/contact-complete/)
- [Contact Complete](https://provigate.com/en/contact-complete/)
- [Contact Confirmation](https://provigate.com/en/contact-confirmation/)
- [お問い合わせ 確認画面](https://provigate.com/contact-confirmation/)
- [プライバシーポリシー](https://provigate.com/privacy-policy/) - ?䤿???ˤĤ??? ???ƥƥ?????: ?䤿???Υ????ȥ??ɥ쥹?? http://localho
- [情報セキュリティ基本方針](https://provigate.com/information-security-basic-policy/)
- [お問い合わせ](https://provigate.com/contact/)
- [Contact](https://provigate.com/en/contact/) - This is the contact form for Provigate, Inc.
- [Career](https://provigate.com/en/career/) - Provigate, Inc. is hiring. Join us in making significant innovations in the era of healthcare revolution! We are looking for individuals who are passionate about creating a better future. Come and be part of our team today!
- [Home](https://provigate.com/en/) - Provigate, Inc. develops blood glucose monitoring sensors and devices for home use and blood glucose monitoring applications for people who are concerned about diabetes or have diabetes.

## ニュース

- [PROVIGATE Reaches Basic Agreement on Capital and Business Alliance with Leading POCT Company, TAUNS](https://provigate.com/en/news/provigate-reaches-basic-agreement-on-capital-and-business-alliance-with-leading-poct-company-tauns/) - Promotion of joint development for the domestic and int
- [PROVIGATE、POCTのリーディングカンパニーであるタウンズとの資本業務提携を進めることに基本合意](https://provigate.com/news/provigate-reaches-basic-agreement-on-capital-and-business-alliance-with-leading-poct-company-tauns/) - タウンズへのC3種優先株式の第三者割当増資、および在宅血糖モニタリングサービスの国内外での普及拡大に向けた共同
- [法人契約ユーザー向け利用規約改定のお知らせ](https://provigate.com/news/notice-regarding-revisions-to-the-terms-of-use-for-corporate-contract-users/) - 平素より、glucoreview®をご利用いただき、ありがとうございます。 このたび、法人契約ユーザー向け利用
- [法人向け利用規約改定のお知らせ](https://provigate.com/news/notice-regarding-revisions-to-corporate-terms-of-service/) - 平素より、glucoreview®をご利用いただき、ありがとうございます。 このたび、法人向け利用規約を改定い
- [プライバシーポリシー改定のお知らせ](https://provigate.com/news/notice-regarding-privacy-policy-revision/) - 平素より、glucoreview®をご利用いただき、ありがとうございます。 このたび、プライバシーポリシーを改
- [Ozu Town, Japan Post, and PROVIGATE Collaborate: Launching a Social Demonstration of a Regional Healthcare Model as Part of R&D for NEDO's "Deep Tech Start-up Support Fund / Deep Tech Start-up Support Program (DTSU)"](https://provigate.com/en/news/ozu-town-japan-post-and-provigate-collaborate-launching-a-social-demonstration-of-a-regional-healthcare-model-as-part-of-rd-for-nedos-deep-tech-start-up-support-fund-deep-tech-start-up-suppo/) - Combining at-home saliva glycated albumin testing with
- [大津町・日本郵便・PROVIGATEが連携：NEDO「ディープテック・スタートアップ支援基金／ディープテック・スタートアップ支援事業（DTSU）」の研究開発の一環として、地域保健モデルの社会実証を開始](https://provigate.com/news/ozu-town-japan-post-and-provigate-collaborate-launching-a-social-demonstration-of-a-regional-healthcare-model-as-part-of-rd-for-nedos-deep-tech-start-up-support-fund-deep-tech-start-up-support-program/) - 郵便局ネットワークに在宅唾液グリコアルブミン検査とデジタルヘルスを組み合わせ、生活習慣病の重症化予防と健康寿命
- [第67回日本糖尿病学会年次学術集会　付設展示のお知らせ](https://provigate.com/news/the-67th-annual-scientific-meeting-of-the-japan-diabetes-society/) - 株式会社Provigateでは、5月17日-19日に東京国際フォーラムにて開催される「第67回日本糖尿病学会年
- [Sponsor Exhibition: The 67th Annual Meeting of the Japan Diabetes Society](https://provigate.com/en/news/sponsor-exhibition-the-67th-annual-meeting-of-the-japan-diabetes-society/) - Provigate will be participating in the 67th Annual Meet
- [World's First Completely Non-Invasive Blood Glucose Monitoring Method Demonstrated](https://provigate.com/en/news/worlds-first-completely-non-invasive-blood-glucose-monitoring-method-demonstrated/) - Glycated albumin, a surrogate marker for blood glucose,
- [第59回糖尿病学の進歩　コーポレートセミナー・シンポジウム・付設展示のお知らせ](https://provigate.com/news/announcement-of-the-59th-diabetology-advances-corporate-seminar-symposium-ancillary-exhibition/) - 株式会社Provigateでは、1月24日-25日に那覇文化芸術劇場なはーと/ホテルコレクティブ/他、にて開催
- [Corporate seminars, Symposiums, and Sponsor Exhibition：The Advances in Diabetology The 59th Annual Post Graduate Course](https://provigate.com/en/news/corporate-seminars-symposiums-and-sponsor-exhibition：the-advances-in-diabetology-the-59th-annual-post-graduate-course/) - Provigate Corporation will participate in the corporate
- [Care Show Japan 2025展示出展のお知らせ](https://provigate.com/news/notice-of-exhibition-at-care-show-japan-2025/) - 株式会社Provigateでは、2月26日（水）～28日（金）に東京ビッグサイトにて開催される「Care Sh
- [Exhibition:Care Show Japan 2025](https://provigate.com/en/news/notice-of-exhibition-at-care-show-japan-2025/) - Provigate will be exhibiting at the Healthcare IT Zone
- [ATTD 2025プレゼンテーション・展示出展のお知らせ](https://provigate.com/news/attd-2025-presentation-exhibition-notice/) - 株式会社Provigateは、2025年3月19日から22日まで、オランダ・アムステルダムで開催される国際学会
- [Presentation and Exhibition : ATTD 2025](https://provigate.com/en/news/attd-2025-presentation-exhibition-notice/) - Provigate will be exhibiting at the 18th International
- [Announcement of Participation in the 85th Scientific Sessions of American Diabetes Association](https://provigate.com/en/news/announcement-of-participation-in-the-85th-scientific-sessions-of-american-diabetes-association/) - Provigate Inc. will be attending at the 85th Scientific
- [第85回米国糖尿病学会参加のお知らせ](https://provigate.com/news/announcement-of-participation-in-the-85th-scientific-sessions-of-american-diabetes-association/) - 株式会社Provigateは、2025年6月20日（金）～23日（月）に米国イリノイ州シカゴのマコーミックプレ
- [第68回日本糖尿病学会年次学術集会　付設展示のお知らせ](https://provigate.com/news/the-68th-annual-meeting-of-the-japan-diabetes-society/) - 株式会社Provigateでは、5月29日-31日にホテルグランヴィア岡山、ラヴィール岡山、岡山コンベンション
- [Sponsor Exhibition: The 68th Annual Meeting of the Japan Diabetes Society](https://provigate.com/en/news/sponsor-exhibition-the-68th-annual-meeting-of-the-japan-diabetes-society/) - Provigate will be exhibiting at the Annexed Exhibition
- [豊田合成株式会社がProvigateの「血糖管理プログラム」を導入 ](https://provigate.com/news/provigate-begins-providing-glucoreview-to-toyoda-gosei/) - 血糖管理プログラムで健康経営支援モデルを構築し、社会実装を推進 株式会社Provigate（代表取締役: 関水
- [Provigate received Health and Medical Information Grant from AMED.](https://provigate.com/en/news/provigate-received-health-and-medical-information-grant-from-amed/) - Development of a System for Inducing Behavioral Change
- [Announcement of Corporate and Service Logo Update](https://provigate.com/en/news/announcement-of-corporate-and-service-logo-update/) - Thank you for your continued support of our company and
- [企業ロゴおよびサービスロゴ変更のお知らせ](https://provigate.com/news/announcement-of-corporate-and-service-logo-update/) - 平素より当社および当社サービスをご利用いただき、誠にありがとうございます。 このたび当社では、ブランドイメージ
- [Provigate Begins Providing “glucoreview®” to Toyoda Gosei](https://provigate.com/en/news/provigate-begins-providing-glucoreview-to-toyoda-gosei/) - Supporting Health and Productivity Management Through S
- [Global Startup EXPO 2025出展のお知らせ](https://provigate.com/news/exhibitionglobal-startup-expo-2025/) - 株式会社Provigateは、2025年9月17日（水）・18日（木）に大阪・夢洲で開催される「Global
- [Exhibition:Global Startup EXPO 2025](https://provigate.com/en/news/exhibitionglobal-startup-expo-2025/) - Provigate Inc. is pleased to announce that we will be e
- [第25回Diabetes Technology Meeting（DTM）パネルセッション・付設展示のお知らせ](https://provigate.com/news/technical-workshop-and-exhibition-dtm2025/) - 株式会社Provigateは、2025年10月28日から30日まで、アメリカ・カリフォルニア州・バーリンゲーム
- [Technical Workshop and Exhibition : DTM2025](https://provigate.com/en/news/technical-workshop-and-exhibition-dtm2025/) - Provigate, Inc. will be exhibiting at the 25th Annual D
- [第40回日本糖尿病合併症学会　付設展示のお知らせ](https://provigate.com/news/exhibitionthe-40th-annual-meeting-of-the-japanese-society-of-diabetic-complications/) - 株式会社Provigateでは、2025年11月14日-15日に都市センターホテルにて開催される「第40回日本
- [Exhibition：the 40th Annual Scientific Meeting of the Japan Society of Diabetic Complications](https://provigate.com/en/news/exhibitionthe-40th-annual-meeting-of-the-japanese-society-of-diabetic-complications/) - Provigate will be exhibiting at the Annexed Exhibition
- [第65回日本臨床化学年次学術集会　企業シンポジウム参加のお知らせ](https://provigate.com/news/symposiumthe-65th-annual-meeting-of-the-japanese-society-of-clinical-chemistry/) - 株式会社 Provigate は、2025年11月7日から9日まで、ウインクあいちにて開催される「第65回日本
- [Symposium：the 65th Annual Meeting of the Japanese Society of Clinical Chemistry](https://provigate.com/en/news/symposium：the-65th-annual-meeting-of-the-japanese-society-of-clinical-chemistry/) - Provigate Inc. is pleased to announce that our CEO, Kos
- [第38回米日カウンシル ビジネス・アドバイザリー・ボード登壇のお知らせ](https://provigate.com/news/meeting-38th-u-s-japan-council-business-advisory-board-meeting/) - 株式会社 Provigate は、2026年1月29日（木）に東京アメリカンクラブで開催される「38th U.
- [Meeting: 38th U.S.-Japan Council Business Advisory Board Meeting](https://provigate.com/en/news/meeting-38th-u-s-japan-council-business-advisory-board-meeting/) - Provigate, Inc. will have its CEO, Koshin Sekimizu, spe
- [Meeting: DOCOMO Ventures Pitch](https://provigate.com/en/news/meeting-docomo-ventures-pitch/) - Provigate, Inc. will be participating in the "DOCOMO Ve
- [ドコモベンチャーズピッチ登壇のお知らせ](https://provigate.com/news/meeting-docomo-ventures-pitch/) - 株式会社Provigateは、2026年4月28日（火）に株式会社NTTドコモ・ベンチャーズが主催する「ドコモ
- [法人向け利用規約改訂のお知らせ](https://provigate.com/news/notice-of-revision-of-terms-of-use-for-corporations/) - 平素より、glucoreviewをご利用いただき、ありがとうございます。 このたび、法人向け利用規約を改訂のう
- [法人向け利用規約改訂のお知らせ](https://provigate.com/news/法人向け利用規約改訂のお知らせ/) - 平素より、glucoreviewをご利用いただき、ありがとうございます。 このたび、法人向け利用規約を改訂のう
- [ユーザー向け利用規約の改訂および名称変更のお知らせ](https://provigate.com/news/notice-of-revisions-to-the-terms-of-use-and-name-change-for-users/) - 平素より、glucoreviewをご利用いただき、ありがとうございます。 当社は、このたび、当社製品サイト（h
- [利用規約改訂のお知らせ](https://provigate.com/news/notice-of-terms-of-use-revision/) - 平素より、glucoreviewをご利用いただき、ありがとうございます。 当社は、このたび、当社製品サイト（h
- [利用規約変更のお知らせ](https://provigate.com/news/notice-of-changes-to-terms-of-use/) - 平素より、glucoreviewをご利用いただき、ありがとうございます。 当社は、このたび、当社製品サイト（h
- [世界初の完全非侵襲な血糖モニタリング法を実証](https://provigate.com/news/worlds-first-completely-non-invasive-blood-glucose-monitoring-method-demonstrated/) - 図1 高速液体クロマトグラフィーを用いた唾液グリコアルブミン（GA）検査法の確立 糖尿病管理指標のグリコアルブ
- [Report on OMEGA Meeting 2025](https://provigate.com/en/news/report-on-omega-meeting-2025/) - On May 7, 2025, the “OMEGA Meeting 2025” organized by t
- [OMEGA Meeting 2025 開催報告](https://provigate.com/news/report-on-omega-meeting-2025/) - 2025年5月7日、東京都港区の Coral Beach にて、OMEGA Study Group 主催による
- [PROVIGATE Establishes U.S. Subsidiary to Expand Preventive Healthcare Services](https://provigate.com/en/news/announcement-of-u-s-subsidiary-establishment/) - PROVIGATE Inc. (Head Office: Bunkyo-ku, Tokyo, Japan; C
- [米国支社設立のお知らせ](https://provigate.com/news/provigate-establishes-u-s-subsidiary-to-expand-preventive-healthcare-services/) - 株式会社PROVIGATE（本社：東京都文京区、代表取締役CEO：関水康伸）は、当社初の海外拠点として、米国支
- [Awarded at the 28th Annual Meeting of the Japanese Telemedicine and Telecare Association](https://provigate.com/en/news/awarded-at-the-28th-annual-meeting-of-the-japanese-telemedicine-and-telecare-association/) - At the 28th Annual Meeting of the Japanese Telemedicine
- [「第28回日本遠隔医療学会学術大会」優秀演題として表彰されました](https://provigate.com/news/awarded-as-an-excellent-presentation-at-the-28th-academic-conference-of-the-japanese-telemedicine-society/) - 「第28回日本遠隔医療学会学術大会」（2024年11月9日（土）～10日（日）岡山コンベンションセンター）にお
- [Provigate Secured 2 Billion JPY to Accelerate Clinical Development of Once-weekly Home Glucose Monitoring ](https://provigate.com/en/news/provigate-secured-2-billion-jpy-to-accelerate-clinical-development-of-once-weekly-home-glucose-monitoring/) - Awarded Japanese Government Grant under Five-Year Start
- [糖尿病発症・重症化予防のProvigateが20億円の資金調達を実施](https://provigate.com/news/provigate-which-helps-prevent-the-onset-and-severity-of-diabetes-raises-2-billion-yen-in-funding/) - スタートアップ育成5か年計画に基づく助成金「NEDO DTSU（DMPフェーズ）」に採択 株式会社Provig
- [Once-weekly GA monitoring with an app to induce behaviour change in people with type 2 diabetes](https://provigate.com/en/news/once-weekly-ga-monitoring-with-an-app-to-induce-behaviour-change-in-people-with-type-2-diabetes/) - Minimally or non-invasive, affordable and easy-to-use m
- [週1回のグリコアルブミン測定×アプリが2型糖尿病を持つ方の血糖管理を改善](https://provigate.com/news/once-weekly-ga-monitoring-with-an-app-to-induce-behaviour-change-in-people-with-type-2-diabetes/) - 低/非侵襲・低コスト・分かりやすい次世代自己血糖モニタリング法の確立へ 発表のポイント ・ 世界で初めて確立し
- [2023年4月5日に開催されるLINK-Jイベント「スタートアップ補正予算ってどういうコト？」にProvigate代表取締役の関水が登壇いたします。](https://provigate.com/news/dr-sekimizu-ceo-of-provigate-will-be-speaking-at-link-j-event-on-5-april-2023-what-does-a-start-up-supplementary-budget-mean/) - https://www.link-j.org/event/post-5808.html
- [新技術開発財団「新技術開発助成」に採択されました。](https://provigate.com/news/selected-for-the-new-technology-development-foundation-new-technology-development-grant/) - 研究科題名：「バイオトランジスタを用いた非侵襲自己血糖値管理デバイスの新技術開発」 第95回（平成27年度第一
- [東京都「ライフサイエンス系ベンチャー等スタートアップ支援事業」に採択されました。](https://provigate.com/news/provigate-received-life-science-venture-start-up-support-project-grant-from-the-tokyo-metropolitan-government/) - 申請事業テーマ：「糖尿病管理･予防のための非侵襲自己血糖値測定器開発事業の実施」 東京都の「ライフサイエンス系
- [Provigate received "Life Science Venture Start-up Support Project" grant from the Tokyo Metropolitan Government.](https://provigate.com/en/news/provigate-received-life-science-venture-start-up-support-project-grant-from-the-tokyo-metropolitan-government/) - Development of non-invasive self-monitoring blood gluco
- [NEDO-STSに採択されました。](https://provigate.com/news/provigate-received-sts-grant-from-nedo/) - テーマ名：「涙液対外診断薬・臨床検査プラットフォームの開発」 国立研究開発法人新エネルギー・産業技術総合開発機
- [Provigate received STS grant from NEDO.](https://provigate.com/en/news/provigate-received-sts-grant-from-nedo/) - Development of a tear fluid clinical testing platform.
- [鶴保内閣府特命担当大臣（知的財産戦略担当）が、東京大学本郷キャンパス内の同大学発ベンチャー企業等を視察され、Provigate代表取締役の関水が意見交換を致しました。](https://provigate.com/news/mr-tsurubo-minister-of-state-for-intellectual-property-strategy-visited-the-university-of-tokyos-hongo-campus-and-exchanged-views-with-dr-sekimizu-ceo-of-provigate/) - https://www.cao.go.jp/minister/1608_y_tsuruho/photo/201
- [Mr Tsurubo, Minister of State for Intellectual Property Strategy, visited the University of Tokyo's Hongo campus and exchanged views with Dr Sekimizu, CEO of Provigate.](https://provigate.com/en/news/mr-tsurubo-minister-of-state-for-intellectual-property-strategy-visited-the-university-of-tokyos-hongo-campus-and-exchanged-views-with-dr-sekimizu-ceo-of-provigate/) - https://www.cao.go.jp/minister/1608_y_tsuruho/photo/201
- [9月26日に開催されるつくばグローバルサイエンスウィークにProvigate代表取締役の関水が登壇いたします。](https://provigate.com/news/dr-sekimizu-ceo-of-provigate-will-be-speaking-at-the-tsukuba-global-science-week-on-26-september/)
- [Dr Sekimizu, CEO of Provigate will be speaking at the Tsukuba Global Science Week on 26 September.](https://provigate.com/en/news/dr-sekimizu-ceo-of-provigate-will-be-speaking-at-the-tsukuba-global-science-week-on-26-september/)
- [AMED「先端計測」に採択されました。](https://provigate.com/news/provigate-received-a-grant-from-amed/) - 研究開発課題名：「モチベーション喚起型血糖コントロール指標測定デバイスの研究開発」 日本医療研究開発機構「平成
- [Provigate received a grant from AMED.](https://provigate.com/en/news/provigate-received-a-grant-from-amed/) - Research and development of motivation-evoking devices
- [R&D Environment Improvement Support Project](https://provigate.com/en/news/rd-environment-improvement-support-project/) - Development of Diagnostics for Non-invasive Blood Gluco
- [東京大学FoundXのウェブサイトにProvigate代表取締役の関水のインタビューが掲載されました。](https://provigate.com/news/an-interview-with-dr-sekimizu-ceo-of-provigate-is-featured-on-the-university-of-tokyo-foundx-website-in-japanese/) - https://foundx.jp/interview/koshin_sekimizu/
- [An interview with Dr Sekimizu, CEO of Provigate, is featured on the University of Tokyo FoundX website. (In Japanese)](https://provigate.com/en/news/an-interview-with-dr-sekimizu-ceo-of-provigate-is-featured-on-the-university-of-tokyo-foundx-website-in-japanese/) - https://foundx.jp/interview/koshin_sekimizu/
- [Provigate received SCA grant from NEDO.](https://provigate.com/en/news/provigate-received-sca-grant-from-nedo/) - Development of motivation-evoking systems to monitor bl
- [A total of JPY 370 million was raised from Daikin, ANRI, Coral Capital, JST and angel investors. This brings the total amount of equity funding raised since the company's foundation to JPY 840 million.](https://provigate.com/en/news/a-total-of-jpy-370-million-was-raised-from-daikin-anri-coral-capital-jst-and-angel-investors-this-brings-the-total-amount-of-equity-funding-raised-since-the-companys-foundation-to-jpy-840-millio/)
- [Provigate received PCA grant from NEDO.](https://provigate.com/en/news/provigate-received-pca-grant-from-nedo/) - Development of an IoT home blood glucose monitoring sys
- [10月21日に開催されるY Combinator および SVJP 共催のイベントにProvigate代表取締役の関水が登壇いたします。](https://provigate.com/news/dr-sekimizu-ceo-of-provigate-will-be-speaking-at-an-event-co-hosted-by-y-combinator-and-svjp-on-21-october/) - https://event.svjp.org/
- [11月25日に開催される「第 2 回 再生医療 EXPO 東京」のイベントにてProvigate代表取締役の関水が登壇いたします。](https://provigate.com/news/dr-sekimizu-ceo-of-provigate-will-be-speaking-at-the-2nd-regenerative-medicine-expo-tokyo-event-on-25-november/) - https://www.m-messe.co.jp/event/detail/6342
- [Dr Sekimizu, CEO of Provigate, will be speaking at the 2nd Regenerative Medicine EXPO Tokyo event on 25 November.](https://provigate.com/en/news/dr-sekimizu-ceo-of-provigate-will-be-speaking-at-the-2nd-regenerative-medicine-expo-tokyo-event-on-25-november/) - https://www.m-messe.co.jp/event/detail/6342
- [日経ビジネスにProvigateの取材記事「糖尿病ケアで血糖値を知る新指標GAとは　東大発ベンチャーが着目」が掲載されました。](https://provigate.com/news/nikkei-business-published-online-an-article-on-provigate-what-is-ga-a-new-indicator-for-blood-glucose-levels-in-diabetes-care-focused-on-by-a-university-of-tokyo-venture-in-japanese/) - https://business.nikkei.com/atcl/gen/19/00110/012000068
- [Nikkei Business published online an article on Provigate: 'What is GA, a new indicator for blood glucose levels in diabetes care, focused on by a University of Tokyo venture'. (In Japanese)](https://provigate.com/en/news/nikkei-business-published-online-an-article-on-provigate-what-is-ga-a-new-indicator-for-blood-glucose-levels-in-diabetes-care-focused-on-by-a-university-of-tokyo-venture-in-japanese/) - https://business.nikkei.com/atcl/gen/19/00110/012000068
- [日経バイオテクにProvigateの金子社外取締役のインタビュー「日本人ベンチャーキャピタリストの草分け、金子恭規氏に聞く(1)」が掲載されました。](https://provigate.com/news/an-interview-with-provigates-external-director-yasunori-kaneko-a-pioneering-japanese-venture-capitalist-1-was-published-online-in-nikkei-biotech-in-japanese/) - https://bio.nikkeibp.co.jp/atcl/news/p1/21/03/10/07945/
- ['An interview with Provigate's external director, Yasunori Kaneko, a pioneering Japanese venture capitalist (1)' was published online in Nikkei Biotech. (In Japanese)](https://provigate.com/en/news/an-interview-with-provigates-external-director-yasunori-kaneko-a-pioneering-japanese-venture-capitalist-1-was-published-online-in-nikkei-biotech-in-japanese/) - https://bio.nikkeibp.co.jp/atcl/news/p1/21/03/10/07945/
- [日経バイオテクにProvigateの金子社外取締役のインタビュー「日本人ベンチャーキャピタリストの草分け、金子恭規氏に聞く(2)」が掲載されました。」](https://provigate.com/news/an-interview-with-provigates-external-director-yasunori-kaneko-a-pioneering-japanese-venture-capitalist-2-was-published-online-in-nikkei-biotech-in-japanese/) - https://bio.nikkeibp.co.jp/atcl/news/p1/21/03/10/07950/
- ['An interview with Provigate's external director, Yasunori Kaneko, a pioneering Japanese venture capitalist (2)' was published online in Nikkei Biotech. (In Japanese)](https://provigate.com/en/news/an-interview-with-provigates-external-director-yasunori-kaneko-a-pioneering-japanese-venture-capitalist-2-was-published-online-in-nikkei-biotech-in-japanese/) - https://bio.nikkeibp.co.jp/atcl/news/p1/21/03/10/07950/
- [日経バイオテクにProvigateの金子社外取締役のインタビュー「日本人ベンチャーキャピタリストの草分け、金子恭規氏に聞く(3)」が掲載されました。](https://provigate.com/news/日経バイオテクにprovigateの金子社外取締役のインタビ/) - https://bio.nikkeibp.co.jp/atcl/news/p1/21/03/10/07951/
- ['An interview with Provigate's external director, Yasunori Kaneko, a pioneering Japanese venture capitalist (3)' was published online in Nikkei Biotech. (In Japanese)](https://provigate.com/en/news/an-interview-with-provigates-external-director-yasunori-kaneko-a-pioneering-japanese-venture-capitalist-3-was-published-online-in-nikkei-biotech-in-japanese/) - https://bio.nikkeibp.co.jp/atcl/news/p1/21/03/10/07951/
- [日経バイオテクにProvigateの金子社外取締役のインタビュー「日本人ベンチャーキャピタリストの草分け、金子恭規氏に聞く(4)」が掲載されました。](https://provigate.com/news/an-interview-with-provigates-external-director-yasunori-kaneko-a-pioneering-japanese-venture-capitalist-4-was-published-online-in-nikkei-biotech-in-japanese/) - https://bio.nikkeibp.co.jp/atcl/news/p1/21/03/10/07952/
- ['An interview with Provigate's external director, Yasunori Kaneko, a pioneering Japanese venture capitalist (4)' was published online in Nikkei Biotech. (In Japanese)](https://provigate.com/en/news/an-interview-with-provigates-external-director-yasunori-kaneko-a-pioneering-japanese-venture-capitalist-4-was-published-online-in-nikkei-biotech-in-japanese/) - https://bio.nikkeibp.co.jp/atcl/news/p1/21/03/10/07952/
- [週刊東洋経済の特集「医療テックベンチャー」にてProvigateが紹介されました。](https://provigate.com/news/provigate-was-introduced-in-the-special-feature-medical-tech-ventures-in-the-weekly-toyo-keizai-in-japanese/) - https://www.google.co.jp/books/edition/%E9%80%B1%E5%88%
- [Provigate was introduced in the special feature 'Medical Tech Ventures' in the Weekly Toyo Keizai. (In Japanese)](https://provigate.com/en/news/provigate-was-introduced-in-the-special-feature-medical-tech-ventures-in-the-weekly-toyo-keizai-in-japanese/) - https://www.google.co.jp/books/edition/%E9%80%B1%E5%88%
- [JSTnews 2021年7月号にProvigate代表取締役の関水のインタビュー「生活に溶け込む血糖センサー 糖尿病の発症や重症化予防へ」が掲載されました。](https://provigate.com/news/interview-with-dr-sekimizu-ceo-of-provigate-blood-glucose-sensors-that-integrate-into-daily-life-to-prevent-the-onset-and-severity-of-diabetes-was-published-in-the-july-2021-issue-of-jstnews-in-japane/) - https://www.jst.go.jp/pr/jst-news/backnumber/2021/20210
- [Interview with Dr Sekimizu, CEO of Provigate, 'Blood glucose sensors that integrate into daily life to prevent the onset and severity of diabetes', was published in the July 2021 issue of JSTnews. (In Japanese)](https://provigate.com/en/news/interview-with-dr-sekimizu-ceo-of-provigate-blood-glucose-sensors-that-integrate-into-daily-life-to-prevent-the-onset-and-severity-of-diabetes-was-published-in-the-july-2021-issue-of-jstnews-in-japane/) - https://www.jst.go.jp/pr/jst-news/backnumber/2021/20210
- [Provigate received a grant from Tokyo Metropolitan Small Business Promotion Agency](https://provigate.com/en/news/provigate-received-a-grant-from-tokyo-metropolitan-small-business-promotion-agency/) - Development of a non-invasive weekly blood glucose mana
- [A total of JPY 910 million in funding was raised from Sparx Group, ANRI and Coral Capital. This brings the total amount of equity funding raised since the company's inception to JPY 1.75 billion.](https://provigate.com/en/news/a-total-of-jpy-910-million-in-funding-was-raised-from-sparx-group-anri-and-coral-capital-this-brings-the-total-amount-of-equity-funding-raised-since-the-companys-inception-to-jpy-1-75-billion/) - For more information, see this press release (in Japane
- [INITIALにProvigate代表取締役の関水のインタビュー「ディープテック・Provigate、起死回生のピボットで世界へ」が掲載されました。](https://provigate.com/news/initial-published-online-an-interview-with-dr-sekimizu-ceo-of-provigate-entitled-deep-tech-provigate-pivots-to-the-world-in-a-wake-up-call-in-japanese/) - https://initial.inc/articles/briefing43
- [INITIAL published online an interview with Dr Sekimizu, CEO of Provigate, entitled 'Deep tech Provigate pivots to the world in a wake-up call'. (In Japanese)](https://provigate.com/en/news/initial-published-online-an-interview-with-dr-sekimizu-ceo-of-provigate-entitled-deep-tech-provigate-pivots-to-the-world-in-a-wake-up-call-in-japanese/) - https://initial.inc/articles/briefing43
- [11月11日に開催されるJETRO主催のシンポジウム「How to nurture global-minded university startups」にProvigate代表取締役の関水が登壇いたします。](https://provigate.com/news/dr-sekimizu-ceo-of-provigate-will-be-speaking-at-the-symposium-how-to-nurture-globally-minded-university-start-ups-organised-by-jetro-on-11-november/) - https://www.jetro.go.jp/usa/topics/global-minded-univer
- [Dr Sekimizu, CEO of Provigate will be speaking at the symposium 'How to nurture globally-minded university start-ups' organised by JETRO on 11 November.](https://provigate.com/en/news/dr-sekimizu-ceo-of-provigate-will-be-speaking-at-the-symposium-how-to-nurture-globally-minded-university-start-ups-organised-by-jetro-on-11-november/) - https://www.jetro.go.jp/usa/topics/global-minded-univer
- [ニュースイッチにProvigate代表取締役の関水のインタビュー「【ディープテックを追え】糖尿病患者の血糖管理の課題解決。その手法は？」が掲載されました。](https://provigate.com/news/interview-with-dr-sekimizu-ceo-of-provigate-on-newswitch-solving-the-challenges-of-blood-glucose-management-for-people-with-diabetes-was-published-online-in-japanese/) - https://newswitch.jp/p/30072
- [Interview with Dr Sekimizu, CEO of Provigate, on Newswitch, "Solving the challenges of blood glucose management for people with diabetes" was published online. (In Japanese)](https://provigate.com/en/news/interview-with-dr-sekimizu-ceo-of-provigate-on-newswitch-solving-the-challenges-of-blood-glucose-management-for-people-with-diabetes-was-published-online-in-japanese/) - https://newswitch.jp/p/30072
- [Ain Group has taken a stake in Provigate.](https://provigate.com/en/news/ain-group-has-taken-a-stake-in-provigate/)
- [Funding of JPY 100 million was raised from Toyoda Gosei. This brings the total amount of equity financing since the company's foundation to JPY 1.85 billion.](https://provigate.com/en/news/funding-of-jpy-100-million-was-raised-from-toyoda-gosei-this-brings-the-total-amount-of-equity-financing-since-the-companys-foundation-to-jpy-1-85-billion/)
- [Provigateの主要株主であるANRIのnoteにProvigate代表取締役の関水の対談記事「テクノロジーは高齢化社会にどう向き合っていくのか？｜高齢化社会 Vol.2」が掲載されました。](https://provigate.com/news/the-interview-how-will-technology-face-the-ageing-society-with-dr-sekimizu-ceo-of-provigate-was-published-online-in-note-of-anri-one-of-the-main-shareholders-of-provigate-in-japanese/) - https://note.com/anri_vc/n/nc4c1ebfce479
- [The interview "How will technology face the ageing society?" with Dr Sekimizu, CEO of Provigate, was published online in note of ANRI, one of the main shareholders of Provigate.(In Japanese)](https://provigate.com/en/news/the-interview-how-will-technology-face-the-ageing-society-with-dr-sekimizu-ceo-of-provigate-was-published-online-in-note-of-anri-one-of-the-main-shareholders-of-provigate-in-japanese/) - https://note.com/anri_vc/n/nc4c1ebfce479
- [東京大学のウェブサイトにProvigate代表取締役の関水のインタビュー「「偶然の起業家」が取り組む糖尿病ケアの新たなツール」が掲載されました。](https://provigate.com/news/an-interview-with-provigate-ceo-sekimizu-new-tools-for-diabetes-care-by-accidental-entrepreneurs-was-published-on-the-university-of-tokyo-website/) - https://www.u-tokyo.ac.jp/focus/ja/features/entrepreneu
- [東洋経済ONLINEにProvigate代表取締役の関水のインタビュー「血糖値の測り方が変われば糖尿病のケアが変わる」が掲載されました。](https://provigate.com/news/an-interview-with-dr-sekimizu-ceo-of-provigate-entitled-new-method-for-diabetes-care-with-breaking-through-glucose-monitoring-was-published-in-toyo-keizai-online-in-japanese/) - https://toyokeizai.net/articles/-/657587
- [An interview with Dr. Sekimizu, CEO of Provigate, entitled 'New method for diabetes care with breaking through glucose monitoring', was published in Toyo Keizai ONLINE. (In Japanese)](https://provigate.com/en/news/an-interview-with-dr-sekimizu-ceo-of-provigate-entitled-new-method-for-diabetes-care-with-breaking-through-glucose-monitoring-was-published-in-toyo-keizai-online-in-japanese/) - https://toyokeizai.net/articles/-/657587
- [9月18日に実施される「第 10 回日本くすりと糖尿病学会学術集会」にProvigate代表取締役の関水が登壇いたします。](https://provigate.com/news/dr-sekimizu-president-of-provigate-will-be-speaking-at-the-10th-annual-meeting-of-the-japanese-association-for-drugs-and-diabetes-which-will-take-place-on-18-september/) - https://www.jpds2022.org/program/program.pdf
- [Dr. Sekimizu, President of Provigate, will be speaking at the 10th Annual Meeting of the Japanese Association for Drugs and Diabetes, which will take place on 18 September.](https://provigate.com/en/news/dr-sekimizu-president-of-provigate-will-be-speaking-at-the-10th-annual-meeting-of-the-japanese-association-for-drugs-and-diabetes-which-will-take-place-on-18-september/) - https://www.jpds2022.org/program/program.pdf
- [10月6日に開催される500 Global主催の「Startup Pitch Challenge」にProvigate代表取締役の関水が登壇いたします。](https://provigate.com/news/dr-sekimizu-ceo-of-provigate-will-be-speaking-at-the-startup-pitch-challenge-organised-by-500-global-on-6-october/)
- [Dr Sekimizu, CEO of Provigate will be speaking at the Startup Pitch Challenge organised by 500 Global on 6 October.](https://provigate.com/en/news/dr-sekimizu-ceo-of-provigate-will-be-speaking-at-the-startup-pitch-challenge-organised-by-500-global-on-6-october/)
- [11月18日に開催される Medical Tech2022（合同説明会）にProvigate代表取締役の関水が登壇いたします。](https://provigate.com/news/dr-sekimizu-ceo-of-provigate-will-be-speaking-at-medical-tech-2022-joint-recruiting-event-on-18-november/) - https://medicaltech2022.peatix.com/?lang=ja
- [2022年11月15日-16日に開催される第9回 日経・FT感染症会議において「議題5 途上国の感染症と産官学協働～結核・マラリア・顧みられない熱帯病・栄養・免疫」にProvigate代表取締役の関水がDiscusserとして参加いたします。](https://provigate.com/news/dr-sekimizu-ceo-of-provigate-will-participate-as-a-discusser-at-the-9th-nikkei-ft-infectious-diseases-conference-on-15-16-november-2022-in-agenda-item-5-infectious-diseases-in-developing-countries-and/) - https://cdc.nikkei.com/program/
- [Dr Sekimizu, CEO of Provigate, will participate as a Discusser at the 9th Nikkei/FT Infectious Diseases Conference on 15-16 November 2022 in 'Agenda item 5: Infectious diseases in developing countries and industry-academia collaboration - TB, malaria, neglected tropical diseases, nutrition and immunity'.](https://provigate.com/en/news/dr-sekimizu-ceo-of-provigate-will-participate-as-a-discusser-at-the-9th-nikkei-ft-infectious-diseases-conference-on-15-16-november-2022-in-agenda-item-5-infectious-diseases-in-developing-countries-and/) - https://cdc.nikkei.com/program/
- [血液グリコアルブミンの安定的な郵送検査法に関する研究論文がClinica Chimica Actaに掲載されました。](https://provigate.com/news/a-research-paper-on-a-stable-postal-test-method-for-blood-glycated-albumin-has-been-published-in-clinica-chimica-acta/) - わずか10µlの微量血液を用いた安定的なグリコアルブミン郵送検査法を開発 グリコアルブミンは、週間平均血糖の指
- [A research paper on a stable postal test method for blood glycated albumin has been published in Clinica Chimica Acta.](https://provigate.com/en/news/a-research-paper-on-a-stable-postal-test-method-for-blood-glycated-albumin-has-been-published-in-clinica-chimica-acta/) - We developed a stable glycated albuminl testing method
- [血液・涙液・唾液に含まれるグリコアルブミンの相関に関する研究論文がDiabetes Research and Clinical Practice に掲載されました。](https://provigate.com/news/a-research-paper-on-the-correlation-between-glycated-albumin-in-blood-tear-and-saliva-has-been-published-in-diabetes-research-and-clinical-practice/) - 血液・涙液・唾液に含まれるグリコアルブミンが相互に強く相関することを世界で初めて実証 グリコアルブミンは、週次
- [A research paper on the correlation between glycated albumin in blood, tear and saliva has been published in Diabetes Research and Clinical Practice.](https://provigate.com/en/news/a-research-paper-on-the-correlation-between-glycated-albumin-in-blood-tear-and-saliva-has-been-published-in-diabetes-research-and-clinical-practice/) - World's first demonstration that glycated albumin in bl
- [Dr Sekimizu, CEO of Provigate will be speaking at LINK-J event on 5 April 2023 "What does a start-up supplementary budget mean?".](https://provigate.com/en/news/dr-sekimizu-ceo-of-provigate-will-be-speaking-at-link-j-event-on-5-april-2023-what-does-a-start-up-supplementary-budget-mean/) - https://www.link-j.org/event/post-5808.html
- [在宅グリコアルブミン測定の普及と標準化を目指すスタディグループの設立に参画​](https://provigate.com/news/participated-in-the-establishment-of-a-study-group-to-promote-and-standardize-home-glycoalbumin-measurement/) - OMEGA Study Groupを設立​ グリコアルブミン（GA）は従来病院の通院検査でしか測定できないバイ
- [Article on behavior change in type 2 diabetes with biweekly GA measurements published in Diabetes Therapy​](https://provigate.com/en/news/article-on-behavior-change-in-type-2-diabetes-with-bi-weekly-ga-measurements-published-in-diabetes-therapy/) - Bi-weekly Glycated Albumin Measurement was Useful to En
- [Provigate and Sysmex has entered into a basic agreement for joint development of POCT for glycated albumin](https://provigate.com/en/news/provigate-and-sysmex-has-entered-into-a-basic-agreement-for-joint-development-of-poct-for-glycated-albumin/) - Realizing the World's First Rapid Home Glycated Albumin
- [Provigate とシスメックスがグリコアルブミンのPOCT共同開発に向けて協議を開始](https://provigate.com/news/provigate-and-sysmex-has-entered-into-a-basic-agreement-for-joint-development-of-poct-for-glycated-albumin/) - 世界初の在宅グリコアルブミン迅速測定の実現に向けて 株式会社Provigate（本社：東京都文京区、代表取締役
- [Luncheon Seminar: The 67th Annual Meeting of the Japan Diabetes Society](https://provigate.com/en/news/the-67th-annual-scientific-meeting-of-the-japan-diabetes-society-luncheon-seminar/) - A luncheon seminar will be held at The 67th Annual Meet
- [第67回日本糖尿病学会年次学術集会　ランチョンセミナーのお知らせ](https://provigate.com/news/the-67th-annual-scientific-meeting-of-the-japan-diabetes-society-luncheon-seminar/) - 第67回日本糖尿病学会年次学術集会にてランチョンセミナーが実施されます。 セミナータイトル 負担の少ない血糖モ
- [隔週GA測定による2型糖尿病の行動変容の論文がDiabetes Therapyに掲載されました​](https://provigate.com/news/article-on-behavior-change-in-type-2-diabetes-with-bi-weekly-ga-measurements-published-in-diabetes-therapy/) - 隔週のGA測定は2型糖尿病患者の行動変容の動機付けに有用であることが示されました​ 東京大学の東京大学病院糖尿
- [Participation in the establishment of a study group to promote and standardize home GA measurement.​](https://provigate.com/en/news/participated-in-the-establishment-of-a-study-group-to-promote-and-standardize-home-glycoalbumin-measurement/) - Establishment of OMEGA Study Group​ Glycated Albumin (G
- [血糖モニタリングのPROVIGATEが臨床検査のH.U.グループ中央研究所と戦略的提携](https://provigate.com/news/provigate-partnered-with-japanese-clinical-testing-giant-h-u-to-develop-an-innovative-blood-glucose-monitoring-service/) - 糖尿病のある方に向けた行動変容支援プログラムの社会普及を目指して 株式会社PROVIGATE (代表取締役:
- [Provigate received "New Technology Development Grant" from the New Technology Development Foundation.](https://provigate.com/en/news/selected-for-the-new-technology-development-foundation-new-technology-development-grant/) - Development of novel technologies for non-invasive self
- [Provigate partnered with Japanese clinical testing giant H.U. to develop an innovative blood glucose monitoring service.](https://provigate.com/en/news/provigate-partnered-with-japanese-clinical-testing-giant-h-u-to-develop-an-innovative-blood-glucose-monitoring-service/) - Provigate partnered with Japanese clinical testing gian
- [豊田合成より1億円の資金調達を実施いたしました。これにより創業以来の株式資金調達の総額は18.5億円となりました。](https://provigate.com/news/funding-of-jpy-100-million-was-raised-from-toyoda-gosei-this-brings-the-total-amount-of-equity-financing-since-the-companys-foundation-to-jpy-1-85-billion/)
- [アイングループと資本提携を行いました。](https://provigate.com/news/ain-group-has-taken-a-stake-in-provigate/)
- [Sparx Group、ANRI、Coral Capitalより総額9.1億円の資金調達を実施いたしました。これにより創業以来の株式資金調達の総額は17.5億円となりました。](https://provigate.com/news/a-total-of-jpy-910-million-in-funding-was-raised-from-sparx-group-anri-and-coral-capital-this-brings-the-total-amount-of-equity-funding-raised-since-the-companys-inception-to-jpy-1-75-billion/)
- [Daikin、ANRI、Coral Capital、JST、及びエンジェル投資家より総額3.7億円の資金調達を実施いたしました。これにより創業以来の株式資金調達の総額は8.4億円となりました。](https://provigate.com/news/a-total-of-jpy-370-million-was-raised-from-daikin-anri-coral-capital-jst-and-angel-investors-this-brings-the-total-amount-of-equity-funding-raised-since-the-companys-foundation-to-jpy-840-million/)
- [東京都中小公社 「TOKYO 戦略的イノベーション促進事業」 に採択されました。](https://provigate.com/news/provigate-received-a-grant-from-tokyo-metropolitan-small-business-promotion-agency/) - 研究課題名：「完全非侵襲な週次郵送血糖管理サービスの開発」 東京都中小企業振興公社「令和4年度 TOKYO 戦
- [AMED 「健康・医療情報」 に採択されました。](https://provigate.com/news/provigate-received-health-and-medical-information-grant-from-amed/) - 研究課題名：「週次グリコアルブミン検査データの医師-患者間共有による糖尿病患者の行動変容誘発・重症化予防システ
- [NEDO-PCAに採択されました。](https://provigate.com/news/nedo-pcaに採択されました。/) - 助成事業名称：「IoT在宅血糖モニタリングシステムの開発」 国立研究開発法人新エネルギー・産業技術総合開発機構
- [NEDO-SCAに採択されました。](https://provigate.com/news/provigate-received-sca-grant-from-nedo/) - 助成事業名称：「モチベーション喚起型在宅血糖モニタリングシステムの開発」 国立研究開発法人新エネルギー・産業技
- [東京都「研究開発環境整備支援事業」に採択されました。](https://provigate.com/news/東京都「研究開発環境整備支援事業」に採択され/) - 申請事業テーマ：「新規涙液バイオマーカーを用いた非侵襲血糖モニタリング用診断薬の開発」 東京都の「研究開発環境
- [Dr Sekimizu, CEO of Provigate will be speaking at Medical Tech 2022 (joint recruiting event) on 18 November.](https://provigate.com/en/news/dr-sekimizu-ceo-of-provigate-will-be-speaking-at-medical-tech-2022-joint-recruiting-event-on-18-november/) - https://medicaltech2022.peatix.com/?lang=ja
- [Dr Sekimizu, CEO of Provigate will be speaking at an event co-hosted by Y Combinator and SVJP on 21 October.](https://provigate.com/en/news/dr-sekimizu-ceo-of-provigate-will-be-speaking-at-an-event-co-hosted-by-y-combinator-and-svjp-on-21-october/) - https://event.svjp.org/
- [An interview with Provigate CEO Sekimizu, 'New tools for diabetes care by 'accidental entrepreneurs'', was published on the University of Tokyo website.](https://provigate.com/en/news/an-interview-with-provigate-ceo-sekimizu-new-tools-for-diabetes-care-by-accidental-entrepreneurs-was-published-on-the-university-of-tokyo-website/) - https://www.u-tokyo.ac.jp/focus/en/features/entrepreneu

## キャリア

- [学生の方、副業の方、転職をご希望の方等随時受け入れ](https://provigate.com/open_positions/学生の方、副業の方、転職をご希望の方等随時受/)
- [CFO・COO候補、事業開発](https://provigate.com/open_positions/cfo・coo候補、事業開発/)
- [医療従事者の方、製薬企業経験者の方](https://provigate.com/open_positions/医療従事者の方、製薬企業経験者の方/)
- [バイオセンサ開発エンジニア](https://provigate.com/open_positions/バイオセンサ開発エンジニア/) - スパッタリング・Ptセンサ・フォトリソ・電気化学・生化学・有機化学・タンパク質工学・μTAS等
- [医療機器開発エンジニア](https://provigate.com/open_positions/医療機器開発エンジニア/) - 電気工学・機械工学・三次元CAD等
- [ITエンジニア](https://provigate.com/open_positions/itエンジニア/) - 行動変容アプリの開発
- [テクニシャン](https://provigate.com/open_positions/テクニシャン/) - HPLC、LC-MS/MS、SDS-PAGEほか生化学一般、有機化学一般
- [Always welcome!](https://provigate.com/en/open_positions/学生の方副業の方転職をご希望の方等随時受け入/)
- [Candidates for a Chief Financial Officer and a Chief Operating Officer. Business developers.](https://provigate.com/en/open_positions/cfo・coo候補、事業開発/)
- [Medical professionals and those with experience in pharmaceutical companies.](https://provigate.com/en/open_positions/医療従事者の方、製薬企業経験者の方/)
- [Technicians](https://provigate.com/en/open_positions/テクニシャン/) - HPLC, LC-MS/MS, SDS-PAGE, general biochemistry, general
- [IT Engineers](https://provigate.com/en/open_positions/itエンジニア/) - Development of behavior change mobile apps.
- [Medical Device Engineers](https://provigate.com/en/open_positions/医療機器開発エンジニア/) - Design and development of Point of Care Testing analyze
- [Engineers](https://provigate.com/en/open_positions/バイオセンサ開発エンジニア/) - Development of biosensors using sputter, Pt electrode,

## Languages

- [日本語](https://provigate.com/)
- [English](https://provigate.com/en/)

## Category

- [MEDIA](https://provigate.com/news_category/media/) - ?????ʤɤξ
- [BUSINESS](https://provigate.com/news_category/business/)
- [SCIENCE](https://provigate.com/news_category/science/) - ?׾??????Υ??åץǡ?????
- [GRANT](https://provigate.com/news_category/grant/) - ????????Ϣ
- [FINANCE](https://provigate.com/news_category/finance/) - ????????Ĵã??Ϣ
- [Others](https://provigate.com/news_category/others/) - ????ν?Ǥ?????ñۤ??䥦???֥????Ȥβ?????????¾???
- [BUSINESS](https://provigate.com/en/news_category/business/)
- [MEDIA](https://provigate.com/en/news_category/media/)
- [SCIENCE](https://provigate.com/en/news_category/science/)
- [GRANT](https://provigate.com/en/news_category/grant/)
- [FINANCE](https://provigate.com/en/news_category/finance/)
- [Others](https://provigate.com/en/news_category/others/)

## Category

- [インターン](https://provigate.com/open_positions_cat/internship/)
- [経営企画本部](https://provigate.com/open_positions_cat/corporate-planning-division/)
- [R&臨床開発本部](https://provigate.com/open_positions_cat/clinical-development-and-regulatory-affairs-division/)
- [R&D / 研究開発](https://provigate.com/open_positions_cat/r-and-d/)
- [Internship](https://provigate.com/en/open_positions_cat/internship/)
- [Research and Development Devision](https://provigate.com/en/open_positions_cat/r-and-d/)
- [Clinical Development and Regulatory Affairs Division](https://provigate.com/en/open_positions_cat/clinical-development-and-regulatory-affairs-division/)
- [Corporate Planning Division](https://provigate.com/en/open_positions_cat/corporate-planning-division/)